Cargando…

Molecular Diagnostics for Dermatology Practical Applications of Molecular Testing for the Diagnosis and Management of the Dermatology Patient /

This textbook presents the current (and near-future) state of affairs of molecular testing as it pertains to the dermatology patient. It focuses on practical applications of molecular diagnostics over a cross-section of dermatologic disease, including melanoma, lymphoma, soft tissue tumors, genoderm...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores principales: Hosler, Gregory A. (Autor), Murphy, Kathleen M. (Autor)
Autor Corporativo: SpringerLink (Online service)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2014.
Edición:1st ed. 2014.
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-642-54066-0
003 DE-He213
005 20220126153701.0
007 cr nn 008mamaa
008 140430s2014 gw | s |||| 0|eng d
020 |a 9783642540660  |9 978-3-642-54066-0 
024 7 |a 10.1007/978-3-642-54066-0  |2 doi 
050 4 |a RL1-803 
072 7 |a MJK  |2 bicssc 
072 7 |a MED017000  |2 bisacsh 
072 7 |a MJK  |2 thema 
082 0 4 |a 616.5  |2 23 
100 1 |a Hosler, Gregory A.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Molecular Diagnostics for Dermatology  |h [electronic resource] :  |b Practical Applications of Molecular Testing for the Diagnosis and Management of the Dermatology Patient /  |c by Gregory A. Hosler, Kathleen M. Murphy. 
250 |a 1st ed. 2014. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 2014. 
300 |a XVIII, 356 p. 83 illus., 79 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Introduction -- Terms and Definitions -- Basics of Molecular Biology and Nucleic Acids -- Principles of the Molecular Basis for Disease -- Molecular Testing Methods -- PCR and PCR-based Assays -- In situ Hybridization -- FISH and Cytogenetics -- Comparative Genomic Hybridization -- Microarray Analysis -- Melanoma -- Cutaneous Lymphoma and Leukemia Cutis -- Soft Tissue tumors -- Genodermatoses -- Infectious Disease -- Viral -- Bacterial and Mycobacterial -- Fungi and Parasites -- Emerging Molecular Applications in Dermatology -- Pharmacogenetics/Pharmacogenomics -- Theranostics. 
520 |a This textbook presents the current (and near-future) state of affairs of molecular testing as it pertains to the dermatology patient. It focuses on practical applications of molecular diagnostics over a cross-section of dermatologic disease, including melanoma, lymphoma, soft tissue tumors, genodermatoses, and infectious disease. It includes practical advice to those ordering molecular tests as well as to those considering performing such tests, providing a potential template for a comprehensive dermatologic molecular diagnostics test menu. Pitfalls of interpretation and algorithmic approaches to testing are included. The textbook is directed towards all readers - clinicians, pathologists, laboratorians, and other inquisitive minds - independent of their level of molecular expertise, to provoke thought or perhaps even change practice. The context for the book is the rapid evolution of the field of molecular diagnostics, which is becoming more pervasive in all disciplines of medicine, including dermatology. This is indeed an exciting time in dermatology. Molecular testing is now incorporated into all aspects of patient management, including diagnostics (identifying and classifying disease), prognostics (predicting disease course), and theranostics (predicting response to therapy). For example, molecular tests are now used to detect germline mutations that result in genodermatoses, somatic genetic events that characterize tumors such as melanoma and sarcomas, and genetic material of otherwise undetectable infectious organisms. For melanoma and lymphoma, testing can potentially predict tumor behavior and modify patient staging. Regarding theranostics, molecular tests that identify specific mutations in proto-oncogenes, such as BRAF and others, are now used to predict which patients will respond to designer targeted therapies. Molecular theranostics has revolutionized the entire treatment paradigm for patients with advanced melanoma, replacing "excise and pray" approaches with personalized medicine. 
650 0 |a Dermatology. 
650 0 |a Pathology. 
650 0 |a Medicine-Research. 
650 0 |a Biology-Research. 
650 1 4 |a Dermatology. 
650 2 4 |a Pathology. 
650 2 4 |a Biomedical Research. 
700 1 |a Murphy, Kathleen M.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783642540653 
776 0 8 |i Printed edition:  |z 9783642540677 
776 0 8 |i Printed edition:  |z 9783662510308 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-3-642-54066-0  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)